Endometrial carcinoma: Two or three entities?

International Journal of Gynecological Cancer

Volumn 8, Issue 3, 1998, Pages 183-188

  Sivridis, E ^a   Fox, H ^b   Buckley, C H ^c  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Endometrial carcinoma

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; DISEASE ASSOCIATION; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; UTERUS SURGERY;

EID: 0031870780     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1998.09806.x     Document Type: Article

References (21)

1. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15: 10-7.
2. Deligdisch L, Cohen CJ. Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 1985; 56: 1452-5.
3. Beckner ME, Mori T, Silverberg SG. Endometrial carcinoma: non-tumor factors in prognosis. Int J Gynecol Pathol 1985; 4: 131-45.
4. Deligdisch L, Holinka CF. Endometrial carcinoma: two diseases? Cancer Detect Prev 1987; 10: 237-46.
5. th edn. New York: Springer-Verlag, 1994: 439-86.
6. Kaku T, Tsukamoto N, Hachisuga T et al. Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 1996; 60: 22-5.
7. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995; 26: 1268-74.
8. Buckley CH, Fox H. Biopsy Pathology of the Endometrium, London: Chapman and Hall, 1989.
9. Silverberg SG, Kurman RJ. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Atlas of Tumor Pathology, Third Series, Fasicle 3. Washington DC. Armed Forces Institute of Pathology, 1992.
10. Creasman W. Announcement. FIGO stages - 1988 revision. Gynecol Oncol 1989; 35: 125-7.
11. Hendrickson MR, Ross JC, Eifel PJ, Martinez R, Kempson RL. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Burg Pathol 1982; 6: 93-108.
12. Abeler VM, Kjorstad KE. Clear cell carcinoma of the endometrium: a histopathological and clinical stuy of 97 cases. Gynecol Oncol 1991; 40: 207-17.
13. Carcangiu ML, Chambers JT. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol 1995; 14: 30-8.
14. Demopoulos RI, Genega E, Vamvakas E, Carlson E, Mittal K. Papillary carcinoma of the endometrium: morphometric predictors of survival. Int J Gynecol Pathol 1996; 15: 110-8.
15. Abeler VM, Vergote IB, Kjorstad KE, Trope CG. Clear cell carcinoma of the endometrium: prognosis and metastatic pattern. Cancer 1996; 78: 1740-7.
16. Spiegel GW. Endometrial carcinoma in situ in postmenopausal women. Am J Surg Pathol 1995; 19: 417-32.
17. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995; 26: 1260-7.
18. Bokhman JV, Chepick DF, Volkova AT, Vishnevsky AS. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 1985; 20: 139-56.
19. Lee KR, Scully RE. Complex endometrial hyperplasia and carcinoma in adolescents and young women 15-20 years of age: a report of 10 cases. Int J Gynecol Pathol 1989; 8: 201-13.
20. Paulsen RJ, Saure MV, Lobo PA. Pregnancy after in-vitro fetilization in a patient with Stage I endometrial carcinoma treated with progestins. Fertil Steril 1990; 54: 735-8.
21. Jeyarjah A, Oram D, Jacobs I. Molecular events in endometrial carcinogenesis. Int J Gynecol Cancer 1996; 6: 425-38.